首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1572383

生物成像试剂市场、机会、成长动力、产业趋势分析与预测，2024-2032

Biological Imaging Reagents Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月13日 | 出版商:

Global Market Insights Inc. | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在慢性病盛行率上升以及研发大量投资的推动下，全球生物成像试剂市场在 2024 年至 2032 年间将呈现 7.3% 的复合年增长率。推动生物成像试剂产业成长的因素包括全球健康意识的提高、成像技术的技术进步以及诊断成像程序数量的增加。随着全球医疗保健系统强调早期疾病检测和个人化医疗，对先进成像试剂的需求激增。此外，人工智慧和机器学习在成像技术中的整合正在提高诊断准确性，进一步推动生物成像试剂市场的成长。

此外，多模式成像技术的日益使用正在增加对生物成像试剂的需求，改变生物医学研究、临床诊断和治疗开发等领域。透过结合 MRI、PET、CT 和萤光显微镜等模式，多模式成像可为生物过程和疾病提供更清晰、更精确的视野。这种整体方法增强了对医疗状况的识别和理解，推动了对与多种模式相容的各种成像试剂的需求。

整个生物成像试剂产业根据产品类型、影像模式、应用、最终用途和地区进行分类。

生物成像试剂市场按产品类型分为造影剂、光学试剂和核试剂，其中造影剂到2023年将占据44.8%的领先份额。。随着医疗保健系统在全球范围内优先考虑诊断的准确性，对提高成像清晰度和准确性的试剂的需求变得至关重要。这一趋势凸显了现代医学对先进影像技术的日益依赖。

生物成像试剂市场的应用领域包括临床诊断、药物发现、研究等，预计到2032年临床诊断将达到97亿美元。关重要。随着医疗保健系统在全球范围内优先考虑诊断的准确性，对提高成像清晰度和准确性的试剂的需求变得至关重要。这一趋势凸显了现代医学对先进影像技术的日益依赖。

北美生物成像试剂产业预计到 2023 年价值 47 亿美元，复合年增长率为 6.9%。北美的生物成像试剂产业得到了其强大的医疗基础设施的支持，其特点是最先进的成像技术和设施。这种先进的基础设施不仅推动了对复杂成像试剂的需求，而且使该地区成为生物医学研究和创新的领导者。此外，该地区在大量公共和私人投资的支持下对研发的承诺，加速了尖端成像技术和试剂的开发和采用。

产业生态系统分析
产业影响力
- 成长动力
  - 慢性病盛行率上升
  - 多模态成像的日益采用
  - 增加研发投入
- 产业陷阱与挑战
  - 严格的政府法规
成长潜力分析
报销场景
监管环境
技术景观
波特的分析
PESTEL分析
差距分析
未来市场趋势

第 4 章：竞争格局

介绍
公司矩阵分析
公司市占率分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按产品类型，2021 - 2032 年

主要趋势
对照试剂
光学试剂
核试剂

第 6 章：市场估计与预测：按影像方式，2021 - 2032 年

主要趋势
核磁共振成像
超音波
X射线和CT
光学成像
核子造影
- 宠物
- SPECT
- 其他核子造影方式

第 7 章：市场估计与预测：按应用分类，2021 - 2032

主要趋势
临床诊断
- 肿瘤学
- 心臟病学
- 神经病学
- 其他临床诊断应用
药物发现与开发
研究与创新
其他应用

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

主要趋势
医院
诊断影像中心
研究和学术机构
製药和生物技术公司
其他最终用户

第 9 章：市场估计与预测：按地区划分，2021 - 2032 年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 10 章：公司简介

Bayer AG
Bracco
Carl Zeiss
Cell Signaling Technology
Danaher
General Electric Company
Guerbet
Jubilant Pharmova Limited
Luminex Corporation
Nikon Corporation
Novartis AG
Olympus Corporation
Promega Corporation
Sartorius AG
Thermo Fisher Scientific Inc.

简介目录

Product Code: 10770

The Global Biological Imaging Reagents Market will show a 7.3% CAGR between 2024 and 2032, fueled by the rising prevalence of chronic diseases and significant investments in research and development. Factors driving the growth of the Biological Imaging Reagents industry include the rising global health awareness, technological advancements in imaging techniques, and the increasing number of diagnostic imaging procedures. As healthcare systems worldwide emphasize early disease detection and personalized medicine, the demand for advanced imaging reagents has surged. Furthermore, the integration of AI and machine learning in imaging technologies is enhancing diagnostic accuracy, further propelling the growth of the biological imaging reagents market.

Further, the growing use of multimodal imaging techniques is boosting the demand for biological imaging reagents, transforming fields like biomedical research, clinical diagnostics, and therapeutic development. By combining modalities like MRI, PET, CT, and fluorescence microscopy, multimodal imaging offers a clearer and more precise view of biological processes and diseases. This holistic method enhances the identification and understanding of medical conditions, fueling the need for a variety of imaging reagents compatible with multiple modalities.

The overall Biological Imaging Reagents Industry is sorted based on product type, image modality, application, end use, and region.

The biological imaging reagents market is segmented by product type into contrast reagents, optical reagents, and nuclear reagents, with contrast reagents commanding a leading share of 44.8% in 2023. The growing emphasis on early disease detection and personalized medicine is driving the demand for specific imaging agents. As healthcare systems globally prioritize precision in diagnostics, the need for agents that enhance imaging clarity and accuracy becomes paramount. This trend underscores the increasing reliance on advanced imaging techniques in modern medicine.

The biological imaging reagents market's application segments include clinical diagnostics, drug discovery, research, and others, with clinical diagnostics expected to reach USD 9.7 billion by 2032. The rising global health awareness and the push for early disease detection are pivotal in driving the demand for imaging agents. As healthcare systems globally prioritize precision in diagnostics, the need for agents that enhance imaging clarity and accuracy becomes paramount. This trend underscores the increasing reliance on advanced imaging techniques in modern medicine.

North America biological imaging reagents industry, valued at USD 4.7 billion in 2023, is set to grow at a CAGR of 6.9%. North America's biological imaging reagents industry is bolstered by its robust healthcare infrastructure, characterized by state-of-the-art imaging technologies and facilities. This advanced infrastructure not only drives the demand for sophisticated imaging reagents but also positions the region as a leader in biomedical research and innovation. Furthermore, the region's commitment to R&D, backed by substantial public and private investments, accelerates the development and adoption of cutting-edge imaging technologies and reagents.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising prevalence of chronic conditions
  - 3.2.1.2 Growing adoption of multi-modal imaging
  - 3.2.1.3 Increasing investments in research and development
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Stringent government regulations
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Porter's analysis
3.8 PESTEL analysis
3.9 Gap analysis
3.10 Future market trends

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Contrast reagents
5.3 Optical reagents
5.4 Nuclear reagents

Chapter 6 Market Estimates and Forecast, By Imaging Modality, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 MRI
6.3 Ultrasound
6.4 X-ray and CT
6.5 Optical imaging
6.6 Nuclear imaging
- 6.6.1 PET
- 6.6.2 SPECT
- 6.6.3 Other nuclear imaging modalities

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Clinical diagnostics
- 7.2.1 Oncology
- 7.2.2 Cardiology
- 7.2.3 Neurology
- 7.2.4 Other clinical diagnostic application
7.3 Drug discovery and development
7.4 Research and innovation
7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Hospitals
8.3 Diagnostic imaging centers
8.4 Research and academic institutes
8.5 Pharmaceutical and biotechnology companies
8.6 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Netherlands
- 9.3.7 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa